Day: December 23, 2023

health news

U.S. Food and Drug Administration issues Complete Response Letter for dasiglucagon in congenital hyperinsulinism for up to three weeks of dosing due to inspection findings at third-party manufacturing facility

Staff December 23, 2023

Company announcement – No. 45 / 2023 U.S. Food and Drug Administration issues Complete Response Letter for dasiglucagon in congenital...

Read More

health news

ISS Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic

Staff December 23, 2023

SOUTH SAN FRANCISCO, Calif., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing...

Read More

health news

ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools

Staff December 23, 2023

Company Urges Stockholders to Vote “FOR” Value Maximizing Transaction at Upcoming Special MeetingBOULDER, Colo., Dec. 22, 2023 (GLOBE NEWSWIRE) --...

Read More

health news

Todos Medical Announces Insolvency Proceedings in Israel

Staff December 23, 2023

NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, Israel, Dec. 22, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd....

Read More

health news

Mobile-health Network Solutions Announces Share Repurchase Program of up to 214,000 Shares

Staff June 5, 2025

health news

Artelo’s Fatty Acid Binding Protein 5 Inhibitor, ART26.12, Compares Favorably to Naproxen in an Osteoarthritis Pain Study

Staff June 5, 2025

health news

Doheny Eye Institute Welcomes Emma Lessieur-Contreras, MD, PhD, as Principal Investigator

Staff June 5, 2025

health news

Precision Optics Expands Facilities to Meet Growing Backlog

Staff June 5, 2025

health news

Cellectar Biosciences Enters into Common Stock Agreements to Raise $2.5 Million Priced at Market Under Nasdaq Rules

Staff June 5, 2025

error: Content is protected !!